Abstract
l-Arginine, the substrate of nitric oxide synthase, is known to exert favorable effects in the prevention and treatment of cardiovascular diseases. In several conditions, including atherosclerosis and ischemia/reperfusion, where oxygen metabolites are thought to mediate endothelial and myocardial injury,l-arginine has protective effects. Here we studied the mechanisms by which l-arginine protects against oxygen radical-induced myocardial injury. Buffer-perfused rat hearts were subjected to oxygen radicals generated by electrolysis or to hypoxanthine and xanthine oxidase, which generates superoxide anions (O⨪2). Both sources of radicals impaired myocardial contractility, whereas l-arginine prevented the impairment. The observation that d-arginine as well as nitric oxide synthase inhibitors, such asN G-nitro-l-arginine but not glycine, had similar cardioprotective effects indicated that the protection might be due to a direct chemical interaction ofl-arginine and its derivatives with oxygen radicals. In support, l-arginine and the derivatives prevented the formation of O⨪2 as determined by sensitive standard methods, whereas glycine did not. The radical scavenging activity ofl-arginine and derivatives was dose-dependent, with an apparent rate constant of approximately 4.8 × 103 M s−1 for the reaction of l-arginine with O⨪2 as determined by electron paramagnetic resonance spectroscopy using 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine (TEMPONE-H) as spin trap. In summary, the results of this study demonstrate protective effects of l-arginine against oxygen radical-induced cardiac injury by free radical scavenging.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|